Iowa Medicaid and tirzepatide
Zepbound for weight loss: no. Prior authorization for moderate to severe sleep apnea with BMI 30 or higher. Mounjaro for weight loss: no; for type 2 diabetes Iowa Medicaid must cover it. Read from Iowa Department of Health and Human Services, Iowa Medicaid documents Nov 6, 2026.
In 2025 Iowa Medicaid paid for 22,499 tirzepatide prescriptions (Mounjaro, Zepbound), 25% of its GLP-1 prescriptions and 22nd of the 50 states and DC. It reimbursed $23.6 million before rebates, $1,050 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 17,387 | $18.2 million | $1,046 |
| Zepbound | 5,112 | $5.4 million | $1,061 |
Iowa plans and prescribing rules
State of Iowa employee PPO plan (Wellmark). The coverage manual for the State of Iowa's National Choice active employee PPO, effective January 1, 2026 and administered by Wellmark, lists weight reduction drugs among the drugs excluded from the pharmacy benefit.
Tirzepatide in the states around Iowa
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Iowa | 17 | $69/moWellmedr | 22,499 | Medicaid Zepbound: No |
| Illinois | 17 | $69/moWellmedr | 36,372 | Medicaid Zepbound: No |
| Minnesota | 17 | $69/moWellmedr | 49,251 | Medicaid Zepbound: Yes |
| Missouri | 16 | $69/moWellmedr | 127,722 | Medicaid Zepbound: Yes |
| Nebraska | 17 | $69/moWellmedr | 6,041 | Medicaid Zepbound: No |
| South Dakota | 17 | $69/moWellmedr | 7,486 | Medicaid Zepbound: No |
| Wisconsin | 17 | $69/moWellmedr | 118,120 | Medicaid Zepbound: Yes |



